MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0000018
Kekule Pharma Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹144.48 Cr
▲ 5% YoY
Net profit · FY 2024
₹3.44 Cr
Net margin 2.4%
EBITDA · FY 2024
₹11.28 Cr
EBITDA margin 7.8%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹19 Cr
Issued & subscribed
Open charges
₹107.64 Cr
Satisfied ₹109.15 Cr
Company age
42 yrs
Est. 1984
Employees · EPFO
158
Provident fund records
About Kekule Pharma Limited
Data last updated:
Kekule Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 29 November 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1984PLC005145. Its GSTIN is 36AABCK3469K1Z8 (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹19 Cr. It is led by directors including Kudaravalli Sridhar (Managing Director) and Kudaravalli Durgarani (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H. No. 8 – 3 – 680 Opp. Vishal Towers Lic Colony Yellareddy Guda, Hyderabad, Telangana, India – 500073.
As per the financials filed for FY 2024, the company reported a revenue of ₹144.48 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹3.44 Cr (net margin 2.4%) and EBITDA of ₹11.28 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company has about 158 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kekule Pharma. As per MCA filings, the company has open charges of ₹107.64 Cr and satisfied charges of ₹109.15 Cr on record. Court records list 14 cases involving the company, including 9 filed by the company and 5 filed against it; 1 case is pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.9 Cr; the latest was in February 2014. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 323 overdue payments to 80 micro and small suppliers.
Kekule Pharma Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0000018). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kekulepharma.com.
Company details
CIN U24231TG1984PLC005145
Registration Number 005145
Incorporation Date 29 November 1984
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0000018
CIN history
Kekule Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG1984PLC005145, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1984PLC005145 | Current |
| U01119AP2006PTC048851 | Previous |
| U24231AP1984PLC005145 | Previous |
Key People
Kudaravalli Sridhar Managing Director Kudaravalli Durgarani Whole-Time Director Kudaravalli Raja Rao Whole-Time Director Recognitions & Rankings of Kekule Pharma
Contact details
Kekule Pharma Limited's registered office is in Hyderabad, Telangana. Its website is kekulepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH. No. 8 – 3 – 680 Opp. Vishal Towers Lic Colony Yellareddy Guda, Hyderabad, Telangana, India – 500073
- IndustryPharma, API Manufacturers
To see the full contact details of Kekule Pharma Limited, buy the company report.
Comprehensive company report
Kekule Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kekule Pharma operates one associated brand: Kekule Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A pharmaceutical company manufacturing high-quality active pharmaceutical ingredients and intermediates. | kekulepharma.com |
Business activity
The main business activity of Kekule Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kekule Pharma Limited, buy the company report.
Financials of Kekule Pharma Limited
FY 2024 filings availableKekule Pharma Limited reported revenue of ₹144.48 Cr (up 5% YoY) for FY 2024.
Revenue · FY 2024
₹144.48 Cr ▲ 5%
Net profit · FY 2024
₹3.44 Cr margin 2.4%
EBITDA · FY 2024
₹11.28 Cr margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 3%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▼ 3%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 5% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹144.48 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.28 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.44 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kekule Pharma Limited, buy the company report.
Board of directors and KMP of Kekule Pharma Limited
Kekule Pharma Limited currently reports 5 directors and 1 key managerial person. 14 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nadella Madhava Rao Also directs: Madhava Hi-Tech Cold Storage Private Limited | Director | 03 Mar 2017 | 9 Years 7 Months | Current |
| Jaswanthi Chittabathini Also directs: Ricer Research Private Limited | Director | 13 Feb 2024 | 2 Years 8 Months | Current |
| Kudaravalli Durgarani Also directs: Premier Klenz Private Limited, Kekule Pharmaceuticals (A.P) Limited, Dura Estates Private Limited and 1 more | Whole-Time Director | 15 Jun 2001 | 25 Years 4 Months | Current |
| Srilakshmi Kudaravalli | Cfo | 03 Mar 2017 | 9 Years 7 Months | Current |
| Kudaravalli Raja Rao Also directs: Premier Klenz Private Limited, Kekule Pharmaceuticals (A.P) Limited, Alpha Energy Systems Limited and 3 more | Whole-Time Director | 26 May 2004 | 22 Years 5 Months | Current |
| Kudaravalli Sridhar Also directs: Alpha Energy Systems Limited, Kekule Life Sciences Limited | Managing Director | 20 Feb 1998 | 28 Years 8 Months | Current |
Auditor
Kekule Pharma Limited is audited by M N Rao Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M N Rao Associates | FY 2024 | 005386S |
Shareholding
The shareholding of Kekule Pharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kekule Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹107.64 Cr
Satisfied charges
₹109.15 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2023 | 100719351 | Others | ₹38.69 Cr | Open | |
| 28 Apr 2022 | 100589844 | Others | ₹58.95 Cr | Open | |
| 30 Jul 2020 | 100359707 | Others | ₹10 Cr | Open | |
| 28 Mar 2022 | 100564420 | Others | ₹2.6 Cr | Satisfied | |
| 09 Sep 2020 | 100373883 | Others | ₹2.77 Cr | Satisfied |
To see the full charge records of Kekule Pharma Limited, buy the company report.
Total charge records: 25 View all charges
Deals & funding
Kekule Pharma Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.9 Cr; the latest was in February 2014.
Total deals
5
Funding rounds
3
Secondary share transfers
2
Disclosed funding
₹6.9 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2014 | Funding round | ₹1.4 Cr | Investors: 2 individuals |
| Jul 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2012 | Funding round | ₹3 Cr | Investors: 4 individuals |
| Sep 2007 | Secondary share transfer | Undisclosed | Buyer: Premier Klenz Private Limited , 3 individuals Seller: Premier Industrial Equipments Private Limited, an individual |
| Mar 2006 | Funding round | ₹2.5 Cr | Investors: Premier Industrial Equipments Private Limited, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kekule Pharma Limited has 14 court cases on record: 9 filed by Kekule Pharma, 5 filed against it. 1 case is pending and 13 are disposed.
Total cases
14
Filed by the company
9
Filed against the company
5
Pending
1
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 3 | 1 |
| High courts | 6 | 2 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd. and 1 other | Disposed |
| High Court, TELANGANA | Court case (MACMA) | Filed against the company by Icici Lombard General Insurance Co.Ltd | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against M/S. Qualitek Pharma | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Southern Power Distribution Company of Telangana Ltd., and 3 others | Disposed |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against M/S. Qualitek Pharma and 2 others | Pending |
To see the full case history of Kekule Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Kekule Pharma Limited was last rated by Care on 01 Apr 2026.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 01 Apr 2026 |
To see the full credit ratings and regulatory alerts of Kekule Pharma Limited, buy the company report.
MSME payment delays
Kekule Pharma Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 323 overdue payments to 80 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 80)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Sayar Chemical Industries | |||
| Sanchem Sophin Private Limited | |||
| Yogi Dye Chem Industries | |||
| an individual supplier | |||
| Unique Control System |
To see the full MSME payment records of Kekule Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Kekule Pharma Limited has a workforce of 158 employees on its EPFO records as of Oct 13, 2025, across 1 active EPFO establishment.
Employee count
158
Active EPFO establishments
1
Employee growth
-0.63%
GST
Kekule Pharma has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCK3469K1Z8 | Telangana | Active | 01 Jul 2017 |
| 37AABCK3469K3Z4 | Andhra Pradesh | Active | 22 Jun 2018 |
To see the full GST registrations and return filing status of Kekule Pharma Limited, buy the company report.
Recent activity
Kekule Pharma Limited has 19 board changes on record since 1998: 7 appointments and 12 cessations. The latest: Jaswanthi Chittabathini ceased to be Additional Director on 07 Mar 2024.
Charges
A charge with Others of Rs. 38.69 Cr registered on 29 Mar 2023 with Charge ID 100719351 was modified on 24 Sep 2025.
AGM
Kekule Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Kekule Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Jaswanthi Chittabathini ceased to be Additional Director.
Appointed
Jaswanthi Chittabathini was appointed as Director.
Charges
A charge with Others of Rs. 58.95 Cr registered on 28 Apr 2022 with Charge ID 100589844 was modified on 26 Sep 2023.
Charges
A charge registered on 28 Mar 2022 via Charge ID 100564420 with Others was fully satisfied on 24 Jul 2023.
Charges
A charge registered on 09 Sep 2020 via Charge ID 100373883 with Others was fully satisfied on 24 Jul 2023.
Charges
A charge registered on 27 Jul 2020 via Charge ID 100353269 with Others was fully satisfied on 24 Jul 2023.
Charges
A charge registered on 01 Mar 2019 via Charge ID 100241667 with Others was fully satisfied on 24 Jul 2023.
Charges
A charge registered on 06 Sep 2017 via Charge ID 100122924 with Others was fully satisfied on 24 Jul 2023.
Charges
A charge registered on 23 Sep 2011 via Charge ID 10317808 with Bank Of Baroda was fully satisfied on 24 Jul 2023.
69 earlier events are in the company report.
Frequently asked questions
Kekule Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 29 November 1984 (42+ years old) and is registered under CIN U24231TG1984PLC005145.
Kekule Pharma has 6 current directors and KMP:
- Kudaravalli Sridhar - Managing Director
- Kudaravalli Durgarani - Whole-Time Director
- Kudaravalli Raja Rao - Whole-Time Director
- Nadella Madhava Rao - Director
- Jaswanthi Chittabathini - Director
- Srilakshmi Kudaravalli - Cfo
The latest financial statements of Kekule Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Kekule Pharma is 36AABCK3469K1Z8, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 37AABCK3469K3Z4 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Kekule Pharma is U24231TG1984PLC005145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kekule Pharma has 14 court cases on record: 9 filed by the company and 5 filed against it. 1 is pending. Most are in the district courts.
Kekule Pharma was incorporated on 29 November 1984, making it 42+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kekule Pharma has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹6.9 Cr; the latest was in February 2014.
Jaswanthi Chittabathini ceased to be Additional Director on 07 Mar 2024. Jaswanthi Chittabathini was appointed as Director on 13 Feb 2024. Kudaravalli Raja Rao ceased to be Managing Director on 16 Feb 2022. Kekule Pharma has 19 board changes on record in total.
Yes, Kekule Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0000018).
Kekule Pharma has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 323 overdue payments to 80 micro and small suppliers. The latest return was filed on 26 Jun 2019.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages